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ABSTRACT 
Objective: This study was carried out to evaluate the efficacy and prescribing pattern of antibiotics in the skin and skin structure infections (SSTIs) 
at tertiary care teaching hospital. 
Methods: In this prospective observational study, an attempt was made to evaluate the efficacy and prescribing pattern of antibiotics. Subjects were 
selected according to the inclusion and exclusion criteria and patient case sheets were analyzed for patient demographic details, results of physical 
examination and laboratory parameters, and prescription pattern. 
Results: Cellulitis was the most common skin and skin structure infection among the subjects, followed by an ulcer. Few patients showed 
discomforts such as pain, swelling, and purulent discharge. Surgical procedure has been done in 76 patients. Out of 99 patients, 11 patients 
showed a prolonged length of stay (LOS) (≥16 d), which is an indication of the poor efficacy of antibiotics. Intravenous to oral antibiotic therapy 
switch was seen in 47 patients, which indicates that the patient’s condition was improved. The mean length of hospital stay was 8.79 d. The 
majority of patients have been discharged within 15 d. Cephalosporins were the most frequently prescribed class of antibiotics in patients with 
skin and soft tissue infections. Metronidazole was the most frequently used antibiotic as monotherapy followed by cefuroxime. 
Piperacillin+Tazobactam was the most frequently used combination antibiotic. This study finds that the antibiotic treatment was efficacious in 
the majority of the patients. 
Conclusion: This study finds that the antibiotic treatment was efficacious in the majority of the patients.  
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INTRODUCTION  
The objective of this study was to evaluate the efficacy and 
prescribing pattern of antibiotics in the skin and skin structure 
infections at a tertiary care teaching hospital. Skin and soft tissue 
infections (SSTIs), also known as skin and skin structure infections, 
include a group of infections that differ in their clinical presentations 
and degrees of severity [1]. 
The majority of skin and soft tissue infections are caused by bacteria 
and are hence referred to as acute bacterial skin and skin structure 
infections (ABSSSIs). Some cases are caused by viruses—most 
notably, 1Tthe varicella-zoster virus (VZV)1T. Similarities in signs and 
symptoms and difficulty in the ability to identify the causative 
organisms promptly make the diagnosis and treatment of skin and 
soft tissue infections challenging in the initial stages. Therefore, 
careful assessment of risk factors and degree of severity, as well as 
obtaining a detailed medical history and performing a physical 
examination are required to appropriately diagnose and manage a 
patient presenting with a skin and soft tissue infection. 
Antimicrobial regimens are often selected empirically based on host 
characteristics, most likely pathogens, and local susceptibility 
patterns, with streamlining according to microbiology culture and 
sensitivity if the causative organisms are isolated [1]. 
Skin and soft tissue infections may involve any or all layers of the 
skin (epidermis, dermis), subcutaneous fat, fascia, or muscle [2]. 
Skin and soft tissue infections are classified as complicated (cSSSIs) 
when the infection has spread to the deeper tissues, surgical 
intervention is required, or the patient has a comorbid condition (e. 
g. diabetes mellitus) that complicates response to treatment [3]. 
Complicated skin and soft tissue infections include necrotizing 
fasciitis, myositis, and gangrene. Uncomplicated skin and skin 
structure infections may result from minor skin abrasions or even 
insect bites and include cellulitis, erysipelas, carbuncles, and 
impetigo [4]. 
According to the 2011 National Statistics of the Healthcare Cost and 
Utilization Project, 3.4 million emergency department visits were 
contributed by skin and soft tissue infections, or 2.6% of all 
emergency department visits, with 13.9% of visits resulting in 
hospitalization [3]. Treating predisposing conditions such as obesity, 
edema, venous insufficiency, and eczema reduces the risk of 
recurrent infections [1]. 
MATERIALS AND METHODS 
Patients having skin and skin structure infections given with at least 
one antibiotic were included in the study. Patients who were not 
willing to participate in the study; who had underlying diseases like 
HIV, leprosy, TB, psoriasis, and outpatients were excluded. Consent 
to participate in the study was obtained from patients prior to the 
study. Permission to conduct the study was obtained from 
Institutional Ethics Committee (BPC/IEC/65/2019-20). Subjects 
were selected as per the inclusion criteria and patient case sheets 
were analyzed for patient demographic details, results of physical 
examination and laboratory parameters and prescription pattern. 
Evaluation of efficacy was done using the following parameters: 
wound healing status and presence/absence of pain using visual 
analogue pain scale, swelling, purulent discharge, intravenous to 
oral switch, surgical interventions, and length of stay. The 
prescription pattern of antibiotics in the skin and soft tissue 
infections was studied. The data collected were analyzed for the 
following parameters: Efficacy and Prescribing pattern. 
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RESULTS AND DISCUSSION 
 
Table 1: Distribution of subjects based on gender 
Gender No. of subjects (N=99) Percentage (%) 
Male 64 64.64 
 Female 35 35.35 
Total 99 99.99 
 
Table 2: Distribution of subjects based on age 
Age (in 
years) 
18-38 39-59 60-80 >80 
No. of 
patients 
Percentage No. of 
patients 
Percentage No. of 
patients 
Percentage No. of 
patients 
Percentage 
Male 14 14.14 22 22.22 25 25.25 3 3.03 
Female 13 13.13 11 11.11 10 10.1 1 1.01 
Total 27 27.27 33 33.33 35 35.35 4 4.04 
 
Table 3: Types of skin and skin structure infections 
Type of SSTI Age grouping Total 
18-38 39-59 60-80 >80 No. of cases (N=99) Percentage (%) 
Cellulitis 8 12 13 4 37 37.37 
Ulcer 1 13 12 0 26 26.26 
Abscess 11 5 6 0 22 22.22 
Wound 2 2 3 0 7 7.07 
Surgical site infection 3 1 1 0 5 5.05 
Necrotizing fasciitis 3 0 0  3 3.03 
Furunculitis 0 0 1 0 1 1.01 
 
Table 4: Efficacy evaluation of antibiotics in skin and soft tissue infections 
Parameters Status Percentage (%) 
Wound Healing Healed–13 13.13 
Healing-80 80.80 
Not healed-6 6.06 
Pain Absent-21 21.21 
Reduced-61 61.61 
Present-17 17.17 
Swelling Absent-48 48.48 
Reduced-42 42.42 
Present-9 9.09 
Purulent discharge Present-19 19.19 
Absent-80 80.80 
Intravenous to oral switch Yes-47 47.47 
No-52 52.52 
Surgical intervention Yes-76 76.76 
No-23 23.23 
Length of stay (d) 0-15: 88 88.88 
16-30: 10 10.10 
31-45: 1 1.01 
46-60: 0 0 
61-75: 0 0 
 
Table 5: Class of antibiotics prescribed in the skin and soft tissue infections 
Class of antibiotics No. of prescriptions with the given class of 
antibiotics (N=99) 
Percentage of a given class of antibiotic in total no. of 
prescriptions 
Cephalosporins 85 85.85 
Penicillin 51 51.51 
Nitroimidazole 41 41.41 
Fluoroquinolones 18 18.18 
Carbapenem 15 15.15 
Lincomycin 5 5.05 
Aminoglycosides 5 5.05 
Oxazolidinone 4 4.04 
Macrolide 1 1.01 
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Table 6: Antibiotics prescribed as monotherapy 
Antibiotics No. of patients (N=99) Percentage (%) 
Metronidazole 40 40.40 
Cefuroxime 39 39.39 
Levofloxacin 18 18.18 
Cefpodoxime 14 14.14 
Meropenem 11 11.11 
Ceftriaxone 6 6.06 
Orpenem 5 5.05 
Clindamycin 5 5.05 
Faropenem 5 5.05 
Linezolid 4 4.04 
Amikacin 4 4.04 
Cefotaxime 4 4.04 
Ciprofloxacin 2 2.02 
Cefoperazone 2 2.02 
Doripenem 1 1.01 
Gentamicin 1 1.01 
Cephalexin 1 1.01 
Cefepime 1 1.01 
Azithromycin 1 1.01 
Ampicillin 1 1.01 
Cefixime 1 1.01 
 
Table 7: Antibiotics prescribed as dual therapy 
Dual therapy of antibiotics No. of patients (N=99) Percentage (%) 
Piperacillin+tazobactam 41 41.41 
Cefuroxime+sulbactam 16 16.16 
Ceftriaxone+sulbactam 15 15.15 
Cefpodoxime+dicloxacillin 12 12.12 
Cefoperazone+sulbactam 10 10.10 
Cefotaxime+sulbactam 9 9.09 
Amoxicillin+dicloxacillin 5 5.05 
Amoxicillin+clavulanic acid 4 4.04 
Cefepime+tazobactam 2 2.02 
Cefuroxime+tazobactam 1 1.01 
Ceftriaxone+tazobactam 1 1.01 
  
Table 8: Prescription pattern of antibiotics in the skin and soft tissue infections 
Drug use indicators Results 
Average no. of drug per encounter 2.22 
Percentage of drugs prescribed by generic name 63.63 
Percentage of encounters with an antibiotic prescribed 100 
Percentage of encounters with an injection prescribed 95.95 
Percentage of drugs prescribed from essential drugs list 83.63 
 
Table 9: History of co-morbidities in study population 
Comorbid condition Frequency Percentage (%) 
Diabetes Mellitus 30 30.30 
Hypertension 22 22.22 
IHD 4 4.04 
AKI 2 2.02 
 
Table 10: Distribution based on body mass index 
BMI No. of patients (N= 99) Percentage (%) 
<18.5 2 2.02 
18.5-24.9 53 53.53 
25-29.9 33 33.33 
≥ 30 11 11.11 
Total 99 99.99 
<18.5: underweight, 18.5-24.9: normal, 25-29.9: overweight, ≥30: obese 
 
The present study was conducted among the patients who got 
admitted to Shamanur Shivashankarappa Institute of Medical 
Science and Research Centre for skin and soft tissue infections for a 
period of 6 mo. This was a prospective observational study. Our 
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goals were to evaluate the efficacy and the prescribing pattern of 
antibiotics in the skin and soft tissue infections. During the study 
period, a total of 99 cases of SSTIs were monitored prospectively. 
In our study, among the 99 individuals, 64 (64.64%) were men and 
35 (35.35%) were women, who suffered from skin and skin 
structure infections. Brittany Cieri [5] et al. reported that 94.82% of 
the patients with skin and soft tissue infections were men. Out of 99 
individuals, the majority of patients belong to the age group 60-80 y 
(35.35%). I. H. Jaaskelainen [6] et al. reported in their study that 
62.93% of the subjects were above 60 y old. Cellulitis (37.37%) was 
found to be the most common skin and skin structure infection 
among the subjects followed by ulcer (26.26%). This finding was 
similar to J. Garau [7] et al. and I. H. Jaaskelainen [8] et al. who also 
found cellulitis being the most common SSTI in their study. In 
contrast, Benjamin A Lipsky [9] et al. found SSI (32%) being the 
most common SSTI and only 27% had cellulitis. 
In this study, the antibiotic treatment was found to be efficacious in 
the majority of the patients. However, the wound was not healed in 
6% of the patients and some of them have shown discomfort such as 
pain (17.17%), swelling (9.09%), and purulent discharge (19.19%) 
despite the antibiotic treatment, which indicates the ineffectiveness 
of the antibiotics. The number of patients who went under surgical 
procedure was 76 (76.76%). The mean length of hospital stay was 
8.79 d. The majority of patients have been discharged within 15 d 
(88.88%). Out of 99 patients, 11(11.11%) patients had a prolonged 
length of stay (≥16 d), which is also an indication of poor efficacy of 
antibiotics. Intravenous to oral antibiotic therapy switch has been 
done in 47 patients, which means that these patients were showing 
improvement in their condition. 
Cephalosporins were the most frequently prescribed class of 
antibiotics. As monotherapy, Metronidazole was used more 
frequently and Piperacillin-Tazobactam was the most prescribed 
antibiotic in dual therapy. Brittany Cieri [5] et al. reported that 
Vancomycin-Beta-lactam/beta-lactamase inhibitor was the most 
commonly prescribed antibiotics (24%) in their study. In another 
study, Krishan Yadav [10] et al. reported that the most common oral 
agent used was cephalexin and the most common parenteral agent 
was cefazolin. The average number of drugs per encounter was 2.22. 
Overall, 95.95% of patients have been prescribed an injectable 
antibiotic, and 63.63% of drugs were prescribed by their generic 
name. 83.63% of prescribed drugs were from the essential drugs list. 
Likewise, Gebre Teklemariam Demoz [11] et al. reported that 52.3% 
of patients had at least one oral and/or injectable antibiotic 
prescribed. The average number of prescribed antibiotics per 
patient was 2.01 in their study. They have also found that the 
majority (97.6%) of antibiotics were prescribed by their generic 
name, and all prescribed antibiotics were from the National 
Essential Medicine List [11]. 
Diabetes, hypertension, ischemic heart disease, acute kidney injury, 
and obesity/overweight were the comorbidities present in the 
patients among which diabetes (30.3%) was found to be the most 
frequent comorbid condition among skin and soft tissue infections 
patients. Similarly, Krishan Yadav [10] et al. and Brittany Cieri [5] et 
al. reported that the most frequent comorbidity was diabetes in 
their study. In our study, overweight/obesity (Body mass index ≥25) 
was identified in 44.44%. Also, Brittany Cieri [5] et al. found that 
53.6% of the subjects were obese/extremely obese. 
The risk of antibiotic failure increases in obese patients due to 
altered pharmacokinetics and pharmacodynamics of these drugs in 
them. Oral antibiotics may not reach the desired site of action due to 
the increased volume of distribution into adipose tissue, increased 
clearance, and inadequate antibiotic penetration in obese patients 
[2]. Studies have shown that patients with diabetes mellitus are at 
an increased risk for skin and soft tissue infections due to damage to 
lymphatic vessels and accompanying lower leg ulceration [5]. Those 
with diabetes mellitus were at an increased risk for failure in our 
study. 
The limitations of this study were lack of culture results, missing 
data which was rectified by seeking help from medical staff and 
patients. The proposed sample size was not achieved, as the time 
available for data collection was less, due to the COVID-19 pandemic. 
CONCLUSION 
Antibiotic treatment remarkably represents the cornerstone for 
achieving optimal therapeutic outcomes in the management of skin 
and soft tissue infections. From the present study, it was found that 
Cephalosporins were the most frequently prescribed class of 
antibiotics. And Metronidazole was most frequently prescribed as 
monotherapy and most of the combinations consisted of 
Piperacillin-Tazobactam. Approximately 20% of them failed the 
treatment. Doing culture tests and treating the patient with the 
specific antibiotic which is active against the isolated organism can 
prevent this treatment failure to a certain extent. Obesity and 
diabetes were found to be predictors of antibiotic treatment failure 
in the skin and soft tissue infection. These risk factors should be 
considered while treating a patient for skin and soft tissue infection. 
The continuous monitoring of prescription and drug use pattern 
studies helps in identifying the problems involved in therapeutic 
decision-making and promotes rational prescribing. 
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